Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodology-Reference-Cited by-同舟云学术

Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodology

Published:2023-06 Issue:6 Volume:55 Page:695-703
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Bonovas Stefanos^ORCID,Piovani Daniele,Pansieri Claudia,Macaluso Fabio Salvatore,Orlando Ambrogio,Festa Stefano,Papi Claudio,Pugliese Daniela,Armuzzi Alessandro

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference57 articles.

1. Crohn's disease;Jewell,2005

2. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses;Piovani;Gastroenterology,2019

3. Ethnic differences in the smoking-related risk of inflammatory bowel disease: a systematic review and meta-analysis;Piovani;J Crohns Colitis,2021

4. Crohn's disease;Baumgart;Lancet,2012

5. ECCO guidelines on therapeutics in Crohn's disease: medical treatment;Torres;J Crohns Colitis,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus;Autoimmunity Reviews;2024-05

2. Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease;Journal of Gastroenterology and Hepatology;2023-05-06

3. Efficacy of early biologic therapy versus late/conventional therapy in children and adolescents with Crohn’s disease: A systematic review and meta-analysis;Saudi Journal of Gastroenterology;2023